GSA Capital Partners’s RxSight RXST Stock Holding History

GSA Capital Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$431K	Buy	89,512 +35,059	+64%	+$212K	0.03%	1093
2026 Q1	$335K	Sell	54,453 -32,267	-37%	-$268K	0.02%	1185
2025 Q4	$904K	Buy	86,720 +14,205	+20%	+$143K	0.08%	425
2025 Q3	$652K	Buy	72,515 +4,743	+7%	+$41.6K	0.05%	674
2025 Q2	$881K	Buy	67,772 +29,316	+76%	+$441K	0.06%	541
2025 Q1	$971K	Buy	38,456 +13,892	+57%	+$413K	0.09%	361
2024 Q4	$845K	Buy	24,564 +3,480	+17%	+$157K	0.06%	523
2024 Q3	$1.04M	Sell	21,084 -14,772	-41%	-$757K	0.08%	444
2024 Q2	$2.16M	Sell	35,856 -1,533	-4%	-$87.6K	0.15%	121
2024 Q1	$1.93M	Buy	+37,389	New	+$1.84M	0.15%	135
2023 Q4	–	Sell	-22,532	Closed	-$628K	–	1867
2023 Q3	$628K	Sell	22,532 -10,650	-32%	-$318K	0.05%	654
2023 Q2	$956K	Buy	+33,182	New	+$738K	0.1%	335

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GSA Capital Partners's RXST Position: Q2 2026 in Review

GSA Capital Partners increased its RxSight (RXST) stake by 64% in Q2 2026, buying an estimated $212K and bringing the position to 89,512 shares worth $431K. The position accounts for 0.03% of the portfolio, ranked #1093.

GSA Capital Partners first reported a position in RXST in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.16M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

GSA Capital Partners held 89,512 shares of RxSight worth $431K as of Q2 2026.
GSA Capital Partners bought 35,059 RxSight shares in Q2 2026, an estimated $212K.
RxSight made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #1093 holding.
GSA Capital Partners first reported a position in RxSight in Q2 2023 and has held it in 12 quarters since.
GSA Capital Partners's RxSight position peaked at $2.16M in Q2 2024.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.